Elanco Animal Health Inc [NYSE: ELAN] stock went on an upward path that rose over 5963603% on Tuesday, amounting to a one-week price decrease of less than -3.43%.
Over the last 12 months, ELAN stock rose by 11.56%. The one-year Elanco Animal Health Inc stock forecast points to a potential downside of -41093017.41. The average equity rating for ELAN stock is currently 1.79, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $6.71 billion, with 496.46 million shares outstanding and 491.95 million shares in the current float. Compared to the average trading volume of 6.09M shares, ELAN stock reached a trading volume of 5963603 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Elanco Animal Health Inc [ELAN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $14.82 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 1.79. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Elanco Animal Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 09, 2024. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Market Perform. The new note on the price target was released on December 02, 2024, representing the official price target for Elanco Animal Health Inc stock. Previously, the target price had yet another drop from $17 to $15, while Morgan Stanley kept a Equal-Weight rating on ELAN stock. On January 05, 2024, analysts increased their price target for ELAN shares from 13 to 20.
The Price to Book ratio for the last quarter was 1.06, with the Price to Cash per share for the same quarter was set at 0.98. Price to Free Cash Flow for ELAN in the course of the last twelve months was 19.34 with Quick ratio for the last quarter at 1.46.
ELAN Stock Performance Analysis:
Elanco Animal Health Inc [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.43. With this latest performance, ELAN shares gained by 6.63% in over the last four-week period, additionally plugging by 15.17% over the last 6 months – not to mention a rise of 11.56% in the past year of trading.
Insight into Elanco Animal Health Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Inc [ELAN] shares currently have an operating margin of 5.40% and a Gross Margin at 43.10%. Elanco Animal Health Inc’s Net Margin is presently recorded at 8.43%.
Return on Equity for this stock inclined to 2.77%, with Return on Assets sitting at 2.77%.
ELAN Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Inc go to 6.20%.
Elanco Animal Health Inc [ELAN] Institutonal Ownership Details
There are presently around $101.48%, or 102.54% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 83.58 million shares, which is approximately 16.9128%. PRIMECAP MANAGEMENT CO/CA/, holding 52.8 million shares of the stock with an approximate value of $$761.94 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $$713.53 million in ELAN stock with ownership which is approximately 10.0056%.
